Investidea: Simulations Plus, потому что спрос есть — значит, promising
Today we have a moderately speculative idea.: take shares in pharmaceutical research software maker Simulations Plus (NASDAQ: SLP), to capitalize on the growth in demand in his field of activity. Growth potential and validity: 28% behind 14 Months; 12% per year for 10 years.